| Non-steroidal anti-inflammatory drugs in Parkinson's disease E Esposito, V Di Matteo, A Benigno, M Pierucci, G Crescimanno, ... Experimental neurology 205 (2), 295-312, 2007 | 281 | 2007 |
| Serotonin control of central dopaminergic function: focus on in vivo microdialysis studies V Di Matteo, G Di Giovanni, M Pierucci, E Esposito Progress in brain research 172, 7-44, 2008 | 197 | 2008 |
| Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders V Di Matteo, M Pierucci, E Esposito, G Crescimanno, A Benigno, ... Progress in brain research 172, 423-463, 2008 | 183 | 2008 |
| Serotonin–dopamine interaction: electrophysiological evidence G Di Giovanni, V Di Matteo, M Pierucci, E Esposito Progress in brain research 172, 45-71, 2008 | 160 | 2008 |
| Acute suppressive and long-term phase modulation actions of orexin on the mammalian circadian clock MDC Belle, ATL Hughes, DA Bechtold, P Cunningham, M Pierucci, ... Journal of Neuroscience 34 (10), 3607-3621, 2014 | 136 | 2014 |
| Central serotonin2C receptor: from physiology to pathology GD Giovanni, VD Matteo, M Pierucci, A Benigno, E Esposito Current topics in medicinal chemistry 6 (18), 1909-1925, 2006 | 103 | 2006 |
| Selective activation of 5-HT2C receptors stimulates GABA-ergic function in the rat substantia nigra pars reticulata: a combined in vivo electrophysiological and neurochemical study RW Invernizzi, M Pierucci, E Calcagno, G Di Giovanni, V Di Matteo, ... Neuroscience 144 (4), 1523-1535, 2007 | 99 | 2007 |
| Selective stimulation of serotonin2C receptors blocks the enhancement of striatal and accumbal dopamine release induced by nicotine administration V Di Matteo, M Pierucci, E Esposito Journal of neurochemistry 89 (2), 418-429, 2004 | 99 | 2004 |
| Molecular and functional interactions between tumor necrosis factor-alpha receptors and the glutamatergic system in the mouse hippocampus: implications for seizure susceptibility S Balosso, T Ravizza, M Pierucci, E Calcagno, R Invernizzi, G Di Giovanni, ... Neuroscience 161 (1), 293-300, 2009 | 98 | 2009 |
| Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function L Abdallah, SJ Bonasera, FW Hopf, L O'Dell, M Giorgetti, M Jongsma, ... Journal of Neuroscience 29 (25), 8156-8165, 2009 | 77 | 2009 |
| Serotonin involvement in the basal ganglia pathophysiology: could the 5-HT2C receptor be a new target for therapeutic strategies? G Di Giovanni, V Di Matteo, M Pierucci, A Benigno, E Esposito Current medicinal chemistry 13 (25), 3069-3081, 2006 | 70 | 2006 |
| Aspirin protects striatal dopaminergic neurons from neurotoxin-induced degeneration: an in vivo microdialysis study V Di Matteo, M Pierucci, G Di Giovanni, A Di Santo, A Poggi, A Benigno, ... Brain research 1095 (1), 167-177, 2006 | 68 | 2006 |
| Acute nicotine induces anxiety and disrupts temporal pattern organization of rat exploratory behavior in hole-board: a potential role for the lateral habenula M Casarrubea, C Davies, F Faulisi, M Pierucci, R Colangeli, L Partridge, ... Frontiers in cellular neuroscience 9, 197, 2015 | 67 | 2015 |
| The neurobiological bases for the pharmacotherapy of nicotine addiction V Di Matteo, M Pierucci, G Di Giovanni, A Benigno, E Esposito Current pharmaceutical design 13 (12), 1269-1284, 2007 | 66 | 2007 |
| Stimulation of serotonin2C receptors blocks the hyperactivation of midbrain dopamine neurons induced by nicotine administration M Pierucci, V Di Matteo, E Esposito Journal of Pharmacology and Experimental Therapeutics 309 (1), 109-118, 2004 | 64 | 2004 |
| The FAAH inhibitor URB597 suppresses hippocampal maximal dentate afterdischarges and restores seizure-induced impairment of short and long-term synaptic plasticity R Colangeli, M Pierucci, A Benigno, G Campiani, S Butini, G Di Giovanni Scientific reports 7 (1), 11152, 2017 | 50 | 2017 |
| Role (s) of the 5‐HT 2C Receptor in the Development of Maximal Dentate Activation in the Hippocampus of Anesthetized Rats G Orban, C Bombardi, A Marino Gammazza, R Colangeli, M Pierucci, ... CNS neuroscience & therapeutics 20 (7), 651-661, 2014 | 47 | 2014 |
| 7‐Nitroindazole Protects Striatal Dopaminergic Neurons against MPP+‐Induced Degeneration: An in Vivo Microdialysis Study V Di Matteo, A Benigno, M Pierucci, DA Giuliano, G Crescimanno, ... Annals of the New York Academy of Sciences 1089 (1), 462-471, 2006 | 40 | 2006 |
| Nitric oxide modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders M Pierucci, S Galati, M Valentino, V Di Matteo, A Benigno, A Pitruzzella, ... CNS & Neurological Disorders-Drug Targets (Formerly Current Drug Targets-CNS …, 2011 | 38 | 2011 |
| Hsp60 response in experimental and human temporal lobe epilepsy AM Gammazza, R Colangeli, G Orban, M Pierucci, G Di Gennaro, ... Scientific reports 5 (1), 9434, 2015 | 36 | 2015 |
